Mumbai/ Pune, 09 November 2024 – Emcure Pharmaceuticals Ltd. announces the launch of a public awareness campaign on stroke prevention with cricket legend, MS Dhoni. Under this initiative, Emcure and Dhoni, through a video urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness.
According to epidemiology studies conducted in India, over 1.8 million people suffer a stroke each year, making it a leading cause of death and disability. Therefore, Emcure has taken upon itself to help raise awareness on brain stroke, its symptoms and understanding the importance of timely intervention to save lives and improve outcomes for countless individuals. Known for his sharp instincts on the field, former and multiple World Cup winning captain, MS Dhoni will now help educate the nation on the critical signs of stroke and the need for swift, decisive action when these symptoms appear.
At the heart of the campaign is the “BEFAST” (1) approach—a simple, memorable acronym that outlines the key symptoms of stroke, making it easier for public to recognize and act swiftly.
- B stands for Balance loss,
- E for sudden Eyesight changes,
- F for Face drooping,
- A for Arm weakness,
- S for Speech difficulties, and
- T signifies the Time to call emergency medical services without delay
Just as every second counts in a cricket match, Dhoni highlights that recognizing these signs and taking immediate action by calling emergency medical support could be the key difference between recovery and lasting impact.
Speaking on the initiative, Dr. N. Ichaporia, Consulting Neurologist Pune shared, “For every minute a stroke goes untreated, the brain loses 1.9 million cells. Immediate care at a capable stroke centre can drastically improve outcomes. With the increasing incidence of strokes in India, prompt measures are essential to make public aware about the importance of early identification and intervention. We emphasize the importance of swift action using the BEFAST method.”
This video is just another initiative to further our commitment to educating communities about stroke prevention.
About Emcure Pharmaceuticals Limited: Emcure is a leading Indian pharmaceuticals company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Known for its commitment to innovation, quality, and patient-centricity, Emcure is an R&D driven company that develops and manufactures a wide range of differentiated pharmaceutical products designed to improve patient health and well-being across several major therapeutic areas.
Established in 1981, Emcure is ranked as the 12th largest pharma company in India in terms of Domestic Sales for MAT June 2024*. Emcure is present in 70+ countries globally including Europe and Canada.
References-
1. Hogge C, Goldstein LB, Aroor SR. Mnemonic utilization in stroke education: FAST and BEFAST adoption by certified comprehensive stroke centers. Front Neurol. 2024 Mar 12;15:1359131.
2. Tadi P, Lui F. Acute Stroke. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan
3. Hollist M, Morgan L, Cabatbat R, Au K, Kirmani MF, Kirmani BF. Acute Stroke Management: Overview and Recent Updates. Aging Dis. 2021 Jul 1;12(4):1000-1009.
4. Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase Thrombolysis for Acute Ischemic Stroke. Stroke. 2020 Nov;51(11):3440-3451.
